Inventor · disambiguated record
Aaron Almeida
Also filed as: ALMEIDA AARON · ALMEIDA AARON M
10 granted patents·4 pending applications·32 citations·filing 2014–2024
86Inventor score
Top patents by PatentIndex Score
14 records- 0195US9932586B2Compositions and methods for inhibiting gene expression of LPAARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·9 cites·39 claims
- 0293US10662427B2Compositions and methods for inhibiting gene expression of LPAARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·6 cites·39 claims
- 0386US11180529B2Alpha-v beta-6 integrin ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Nov 23, 2021·3 cites·18 claims
- 0486US10927373B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Feb 23, 2021·2 cites·20 claims
- 0586US9976141B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD MADISON INC·Filed 2016·Granted May 22, 2018·5 cites·32 claims
- 0686US2025115907A1Compositions and methods for inhibiting gene expression of lpaARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0785US9487556B2Polyconjugates for delivery of RNAi triggers to tumor cells in vivoARROWHEAD MADISON INC·Filed 2014·Granted Nov 8, 2016·6 cites·18 claims
- 0876US9803201B2Disulfide-containing alkyne linking agentsARROWHEAD MADISON INC·Filed 2016·Granted Oct 31, 2017·1 cites·14 claims
- 0974US11840688B2Compositions and methods for inhibiting gene expression of Hif2alphaARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Dec 12, 2023·0 cites·20 claims
- 1069US12173086B2Alpha-v beta-6 integrin ligands and uses thereofARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Dec 24, 2024·0 cites·15 claims
- 1169US2020263179A1Compositions and methods for inhibiting gene expression of lpaARROWHEAD PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1262US10047361B2Disulfide-containing alkyne linking agentsARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Aug 14, 2018·0 cites·12 claims
- 1357US2019062748A1Polyconjugates for Delivery of RNAi triggers to Tumor Cells In VivoARROWHEAD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1451US2017022497A1Polyconjugates for Delivery of RNAi triggers to Tumor Cells In VivoARROWHEAD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →